National Bank of Canada
CATX icon

National Bank of Canada’s Perspective Therapeutics CATX Stock Holding History

National Bank of Canada’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.41K Sell
582
-73
-11% -$308 ﹤0.01% 2594
2025
Q4 		$1.79K Hold
655
– – ﹤0.01% 2577
2025
Q3 		$2.27K Hold
655
– – ﹤0.01% 2579
2025
Q2 		$2.26K Hold
655
– – ﹤0.01% 2606
2025
Q1 		$1.4K Sell
655
-10,345
-94% -$31K ﹤0.01% 2545
2024
Q4 		$35.1K Buy
11,000
+10,998
+549,900% +$89.8K ﹤0.01% 2043
2024
Q3 		$27 Buy
+2
New +$27 ﹤0.01% 2626

Other funds holding CATX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

National Bank of Canada's CATX Position: Q1 2026 in Review

National Bank of Canada reduced its Perspective Therapeutics (CATX) stake by 11% in Q1 2026, selling an estimated $308 and leaving 582 shares worth $2.41K. The position accounts for ﹤0.01% of the portfolio, ranked #2594.

National Bank of Canada first reported a position in CATX in Q3 2024 and has held it in 7 quarters since. The position peaked at $35.1K in Q4 2024. 138 funds tracked by Wall St. Rank hold CATX as of Q1 2026.

  • National Bank of Canada held 582 shares of Perspective Therapeutics worth $2.41K as of Q1 2026.
  • National Bank of Canada sold 73 Perspective Therapeutics shares in Q1 2026, an estimated $308.
  • Perspective Therapeutics made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2594 holding.
  • National Bank of Canada first reported a position in Perspective Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • National Bank of Canada's Perspective Therapeutics position peaked at $35.1K in Q4 2024.
  • 138 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.